In Vitro Non-Genomic Effects of Calcifediol on Human Preosteoblastic Cells

Several recent studies have demonstrated that the direct precursor of vitamin D-3, the calcifediol [25(OH)D-3], through the binding to the nuclear vitamin D receptor (VDR), is able to regulate the expression of many genes involved in several cellular processes. Considering that itself may function as a VDR ligand, although with a lower affinity, respect than the active form of vitamin D, we have assumed that 25(OH)D-3 by binding the VDR could have a vitamin's D-3 activity such as activating non-genomic pathways, and in particular we selected mesenchymal stem cells derived from human adipose tissue (hADMSCs) for the in vitro assessment of the intracellular Ca2+ mobilization in response to 25(OH)D-3. Our result reveals the ability of 25(OH)D-3 to activate rapid, non-genomic pathways, such as an increase of intracellular Ca2+ levels, similar to what observed with the biologically active form of vitamin D-3. hADMSCs loaded with Fluo-4 AM exhibited a rapid and sustained increase in intracellular Ca2+ concentration as a result of exposure to 10(-5) M of 25(OH)D-3. In this work, we show for the first time the in vitro ability of 25(OH)D-3 to induce a rapid increase of intracellular Ca2+ levels in hADMSCs. These findings represent an important step to better understand the non-genomic effects of vitamin D-3 and its role in endocrine system.

Automated summary

Recent studies have shown that 25(OH)D-3 can activate rapid non-genomic pathways by binding to VDR, leading to an increase in intracellular Ca2+ levels similar to the biologically active form of vitamin D-3. This work demonstrates for the first time the ability of 25(OH)D-3 to induce a rapid increase in intracellular Ca2+ levels in hADMSCs in vitro.